Skip to main content Accessibility help
×
×
Home

Measles and rubella seroprevalence in a population of young adult blood donors, France 2013

  • D. Antona (a1), P. Morel (a2), C. Jacquot (a2), L. Fonteneau (a1), J. Dina (a3), C. Vauloup-Fellous (a4), L. Gimeno (a2), A. Degeorges (a2), P. Gallian (a5) and D. Lévy-Bruhl (a1)...
Abstract

As part of the evaluation of the French plan for the elimination of measles and rubella, we conducted a seroprevalence survey in 2013, aimed at updating seroprevalence data for people 18–32 years old. A secondary objective was to estimate measles incidence in this population during the 2009–2011 outbreak, and thus estimate the exhaustiveness of measles mandatory reporting. We used a cross-sectional survey design, targeting blood donors 18–32 years old, living in France since 2009, who came to give blood in a blood collecting site. We included 4647 people in metropolitan France, 806 people in Réunion Island and 496 in the French Caribbean. A further 3942 individuals were interviewed in the south-east region of metropolitan France to estimate the exhaustiveness of measles mandatory reporting. One of the main findings of this survey is that the proportion of people 18–32 years old susceptible to both measles and rubella infections remained high in France in 2013, 9.2% and 5.4%, respectively, in metropolitan France, even after the promotion campaigns about vaccination catch-up during and following the major measles epidemic in 2009–2011. Applying our results to French census data would suggest that around 1 million people aged 18–32 years old are currently susceptible to measles in France, despite this age group being one of the vaccination targets of the national measles elimination plan. Another important finding is that only an estimated 45% of the true number of cases in this age group was actually notified, despite notification being mandatory.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Measles and rubella seroprevalence in a population of young adult blood donors, France 2013
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Measles and rubella seroprevalence in a population of young adult blood donors, France 2013
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Measles and rubella seroprevalence in a population of young adult blood donors, France 2013
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
Author for correspondence: D. Antona, E-mail: denise.antona@santepubliquefrance.fr
References
Hide All
1.World Health Organization Regional Office for Europe. Eliminating measles and rubella and prevention congenital rubella infection. WHO European Region strategic plan 2005–2010. Available at http://www.euro.who.int/document/E87772.pdf (Accessed 11 May 2018).
2.World Health Organization Regional Office for Europe. Regional Committee for Europe. Sixtieth session; 2010. Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and sustained support for polio-free status in the WHO European Region. Available at http://www.who.int/immunization/sage/3_Resolution_EURO_RC60_eRes12.pdf (Accessed 11 May 2018).
3.World Health Organization Regional Office for Europe (2015) European Vaccine Action Plan 2015–2020. Copenhagen: World Health Organization. Available at http://www.euro.who.int/__data/assets/pdf_file/0007/255679/WHO_EVAP_UK_v30_WEBx.pdf (Accessed 11 May 2018).
4.Ministère de la Santé et des Solidarités. Plan d’élimination de la rougeole et de la rubéole congénitale en France, 2005–2010. Available at http://www.sante.gouv.fr/IMG/pdf/plan_elimination_rougeole.pdf (Accessed 11 May 2018).
5.Antona, D et al. (2013) Measles elimination efforts and 2008–2011 outbreak, France. Emerging Infectious Diseases 19, 357364.
7.Lepoutre, A et al. (2013) Seroprevalence of vaccine preventable diseases and of five other infectious diseases in France. Results of two national surveys, 2008–2010. Bulletin Epidémiologique Hebdomadaire, 526534. Available at http://invs.santepubliquefrance.fr/beh/2013/41-42/2013_41-42_1.html (Accessed 11 May 2018).
8.Haut Conseil de la santé publique. Avis relatif à l'actualisation des recommandations vaccinales contre la rougeole pour les adultes, 11 février 2011. Available at http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=198 (Accessed 11 May 2018).
9.Ramsay, M. A strategic framework for the elimination of measles in the European Region. Copenhagen: Expanded Programme on Immunization in the European Region of WHO, 1999 (EUR/ICP/CMDS 01 01 05). Available at http://www.euro.who.int/__data/assets/pdf_file/0003/119802/E68405.pdf (Accessed 11 May 2018).
10.Erdman, DD et al. (1993) Immunoglobulin M antibody response to measles virus following primary and secondary vaccination and natural virus infection. Journal of Medical Virology 41, 4448.
11.Krugman, S (1983) Further-attenuated measles vaccine: characteristics and use. Reviews of Infectious Diseases 5, 477481.
12.Strebel, PM et al. (2013) Measles vaccines. In Plotkin, SA and Orenstein, WA (eds), Vaccines, 6th Edn. Philadelphia: Saunders Elsevier company, pp. 352387.
13.Haute autorité de santé. Avis n°2018.0001/AC/SEESP du 10 janvier 2018 du collège de la Haute Autorité de santé concernant le projet de décret relatif à la vaccination obligatoire, pris en application de l'article 49 de la loi n° 2017-1836 du 30 décembre 2017 de financement de la sécurité sociale pour 2018. Available at https://www.has-sante.fr/portail/upload/docs/application/pdf/2018-01/avis_n2018_0001_du_10_janvier_2018_du_college_de_la_haute_autorite_de_sante_concernant_le_projet_de_de.pdf (Accessed 11 May 2018).
14.Santé publique France. Measles epidemiological bulletin. Available at http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Rougeole/Points-d-actualites (Accessed 25 September 2018).
15.Kretsinger, K et al. (2017) Transitioning lessons learned and assets of the global polio eradication initiative to global and regional measles and rubella elimination. Journal of Infectious Diseases 216(suppl. 1), S308S315.
16.Heywood, AE et al. (2009) Elimination of endemic measles transmission in Australia. Bulletin of the World Health Organisation 87, 6471.
17.Peltola, H et al. (2008) Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme. Lancet Infectious Diseases 8, 796803.
18.Santé publique France. Measles-Mumps-Rubella vaccine coverage in France. Available at http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Couverture-vaccinale/Donnees/Rougeole-rubeole-oreillons. (Accessed 25 September 2018).
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed